Patient-Oriented Evidence That Matters
Simple Clinical Prediction Rule Determines Risk of Heart Failure with Preserved Ejection Fraction
Am Fam Physician. 2019 May 15;99(10):online.
Which patients with unexplained dyspnea are more likely to have heart failure with preserved ejection fraction (HFPEF [diastolic heart failure]) as the cause?
A simple clinical prediction rule using noninvasive data can identify patients at low, moderate, and high risk for HFPEF. Although validated in a separate group of patients, the validation group was from the same center, so prospective validation should still be performed in a separate population by another group of investigators. (Level of Evidence = 2b)
The authors identified patients who had been referred to the Mayo Clinic for unexplained dyspnea and underwent invasive testing. The reference standard was right-sided coronary catheterization, with measurement of pressures at rest and, if necessary, during exercise. Predictors were ascertained by chart review. This is ordinarily a red flag, but in this case the predictors were relatively unambiguous (e.g., body mass index, number of medications for hypertension) and the chart review was done in parallel by two investigators using clear prespecified definitions for each variable. The derivation population consisted of 414 consecutive patients, 64% of whom had HFPEF. The validation population was 100 consecutive patients at the same center, with a prevalence of HFPEF of 61%. The mean age of participants was 56 years for those with noncardiac dyspnea and 68 years for those with HFPEF; 60% were women. Logistic regression was used to identify independent predictors, and points were assigned to each predictor based on the beta-coefficient. The independent predictors were body mass index greater than 30 kg per m2 (2 points), taking two or more antihypertensive drugs (1 point), paroxysmal or persistent atrial fibrillation (3 points), Doppler echocardiogram with pulmonary artery systolic pressure greater than 35 mm Hg, 60 years or older, and Doppler echocardiogram showing an E/e ratio of more than nine. In the validation group, the o
Editor's Note: Dr. Ebell is Deputy Editor for Evidence-Based Medicine for AFP and cofounder and Editor-in-Chief of Essential Evidence Plus.
POEMs (patient-oriented evidence that matters) are provided by EssentialEvidence Plus, a point-of-care clinical decision support system published by Wiley-Blackwell. For more information, please see http://www.essentialevidenceplus.com. Copyright Wiley-Blackwell. Used with permission.
For definitions of levels of evidence used in POEMs, see https://www.essentialevidenceplus.com/product/ebm_loe.cfm?show=oxford.
To subscribe to a free podcast of these and other POEMs that appear in AFP, search in iTunes for “POEM of the Week” or go to http://goo.gl/3niWXb.
This series is coordinated by Sumi Sexton, MD, Editor-in-Chief.
A collection of POEMs published in AFP is available at https://www.aafp.org/afp/poems.
Want to use this article elsewhere? Get Permissions